Keryx Biopharma Stock Price (NASDAQ:KERX)

Add to My Stocks
$5.92 $0.02 (0.34%) KERX stock closing price Apr 28, 2017 (Closing)
Keryx Biopharma
28 APR 2017
amigobulls logo
KERX hand_up
KERX vs S&P 500
Closing Price: Apr 28, 2017
$5.92 ( 0.34%)
S&P 500
2384.2 ( -0.19%)
52 Week Price Range
1 Year Return: 12.17%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Keryx Biopharma Snapshot Video

12 5 2

KERX Stock Details

Prev Close* : $5.90
Market Cap:
Day Low: $5.82
52 Week Low: $4.03
Open: $5.9
Volume: 744629
Day High: $5.97
52 Week High: $7.80

Latest Stock Market News

Latest Articles

Keryx Biopharma News - From Partners

KERX Stockcharts

View KERX PE ratio, PS ratio stocks charts and compare with peers.
KERX Chart
Note: Compare Keryx Biopharma stock price history with the index and industry peers.

Keryx Biopharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Keryx Biopharma Financial Ratios

Asset Turnover
Receivables Turnover

KERX Industry Peers

Company Price Change (%)
Revance (RVNC)21.751.55 (6.65%)
Anika Therapeutics (ANIK)46.130.35 (0.76%)
Ardelyx (ARDX)13.40.5 (3.6%)
Akebia Therapeutics (AKBA)13.180.05 (0.38%)
Fibrogen (FGEN)280.05 (0.18%)
Affymax (AFFY)0.050 (0%)
Japan Tob Inc (JAPAY)16.840.06 (0.36%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MiMedx (MDXG)12.691.29 (11.32%)
Regeneron Pharma (REGN)388.4921.87 (5.97%)
Evogene (EVGN)5.360.3 (5.93%)
Sarepta Therapeutics (SRPT)36.261.54 (4.44%)
Acorda Therapeutics (ACOR)16.150.6 (3.86%)
Alkermes (ALKS)58.251.95 (3.46%)
Heska (HSKA)108.253.03 (2.88%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017
CompanyPriceChange (%)
Sorrento Therapeutics (SRNE)1.950.15 (7.14%)
Revance (RVNC)21.751.55 (6.65%)
ZIOPHARM Oncology (ZIOP)7.040.47 (6.26%)
Alder BioPharma (ALDR)20.051.3 (6.09%)
Mirati Therapeutics (MRTX)4.550.23 (4.82%)
Idera Pharma (IDRA)2.350.1 (4.08%)
Curis (CRIS)2.420.1 (3.97%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017

Keryx Biopharmaceuticals Stock News - Partner Headlines

Keryx Biopharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues31.98M13.68M10.82M7M-
Net Income-161.09M-123.14M-111.51M-46.73M-22.72M
Total Operating Expense114.05M118.1M121.55M54.07M27.07M
view Keryx Biopharmaceuticals income statement
balance sheet20162015201420132012
Total Assets141.42M258.68M103.62M60.76M18.56M
Total Liabilities149.72M171.75M30.14M15.36M8.07M
Shareholders Equity-8.29M86.93M73.48M45.4M10.49M
view Keryx Biopharmaceuticals balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-7.94M-35.57M2.55M6.4M-1.6M
Net Cash From (Used By) Operating Activities-86.6M-127.45M-81M-34.31M-24.76M
Increase (Decrease) In Prop Plant And Equipment-2.07M-2.77M-1.48M-0.34M-0.02M
view Keryx Biopharmaceuticals cashflow statement

Keryx Biopharma Stock Message Board

Keryx Biopharma stock price ended the last trading day at 5.9. Keryx Biopharma market capitalization is 642.84M and it represents the total market value of KERX stock. Keryx Biopharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Keryx Biopharma stock price and Keryx Biopharma share price mean the same thing. 508833 KERX shares were traded yesterday, and Keryx Biopharma stock chart shows that the KERX stock quote hit a day high of 6 and day low of 5.87. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of KERX, view Keryx Biopharma stock price history.